Jarrar Mu'taman, Abusalah Mai Abdel Haleem, Albaker Waleed, Al-Bsheish Mohammad, Alsyouf Adi, Al-Mugheed Khalid, Issa Marwan Rasmi, Alumran Arwa
Vice Deanship for Development and Community Partnership, Imam Abdulrahman Bin Faisal University, Dammam, Saudi Arabia.
Department of Medical Education, King Fahd Hospital of the University, Al-Khobar, Saudi Arabia.
Saudi J Med Med Sci. 2023 Jan-Mar;11(1):1-10. doi: 10.4103/sjmms.sjmms_394_22. Epub 2023 Jan 14.
The prevalence of type 2 diabetes mellitus (T2DM) has increased worldwide, including in Saudi Arabia.
To systematically review the available literature and assess the pooled prevalence of T2DM in Saudi Arabia between 2000 and 2020.
Observational studies that reported quantitative estimates of the prevalence of T2DM as their main outcome, included the general population of Saudi Arabia, and were published between 2000-2020 and in English were retrieved using three electronic databases (namely, CINAHL, Medline via PubMed, and Web of Science). Retrieved studies were screened, and relevant data were extracted. The Joanna Briggs Institute Critical Appraisal guideline was used to assess the methodological quality of included studies. A random-effects model was used to estimate the prevalence of T2DM.
Twenty-three studies were included in the systematic review, of which 19 were included in the meta-analysis (total pooled population: 258,283). The overall pooled prevalence of T2DM in Saudi Arabia was 16.4% (95% CI: 11.6-17.5). However, there was heterogeneity in the results of the studies [I = 99.31%, < 0.0001] and the summary values varied from 3.18% (95% CI: 1.46-5.95) to 94.34% (95% CI: 89.53-97.38). Although the prevalence of T2DM by age varied across studies, in most studies, it was higher among the older age groups. In addition, the prevalence of diabetes widely varied across the different geographical regions of Saudi Arabia.
This is the first meta-analysis that determined the pooled prevalence of T2DM in Saudi Arabia, and it revealed a high prevalence over the past two decades. However, owing to data collection inconsistencies in the identified studies, neither the modifiable (such as obesity, educational status, emotional support, etc.) nor the non-modifiable (such as gender and age) risk factors of T2DM could be determined, thereby indicating the need for a nationally collective effort in determining these factors.
2型糖尿病(T2DM)在全球范围内的患病率都有所上升,沙特阿拉伯也不例外。
系统回顾现有文献,评估2000年至2020年沙特阿拉伯T2DM的合并患病率。
检索了三个电子数据库(即CINAHL、通过PubMed检索的Medline和科学网),纳入以T2DM患病率的定量估计作为主要结果、涵盖沙特阿拉伯普通人群、于2000年至2020年期间发表且为英文的观察性研究。对检索到的研究进行筛选,并提取相关数据。采用乔安娜·布里格斯研究所的批判性评价指南评估纳入研究的方法学质量。使用随机效应模型估计T2DM的患病率。
23项研究纳入了系统评价,其中19项纳入了荟萃分析(总合并人群:258,283)。沙特阿拉伯T2DM的总体合并患病率为16.4%(95%CI:11.6 - 17.5)。然而,研究结果存在异质性[I² = 99.31%,P < 0.0001],汇总值从3.18%(95%CI:1.46 - 5.95)到94.34%(95%CI:89.53 - 97.38)不等。尽管不同研究中T2DM的年龄患病率有所不同,但在大多数研究中,老年组的患病率更高。此外,沙特阿拉伯不同地理区域的糖尿病患病率差异很大。
这是第一项确定沙特阿拉伯T2DM合并患病率的荟萃分析,结果显示在过去二十年中患病率较高。然而,由于纳入研究中数据收集的不一致性,无法确定T2DM的可改变风险因素(如肥胖、教育程度、情感支持等)和不可改变风险因素(如性别和年龄)这表明需要全国共同努力来确定这些因素。